Workflow
捷诺飞生物科技:高性能生物3D打印机助力再生医学新发展
DT新材料·2025-07-03 13:38

Core Viewpoint - Hangzhou Regenovo Biotechnology Co., Ltd. is a leading provider of biological 3D printing technology and solutions in regenerative medicine, showcasing its advanced products and research at the upcoming 2025 Polymer 3D Printing Materials Summit Forum [2][35]. Group 1: Company Overview - Founded in 2013, Hangzhou Regenovo Biotechnology specializes in biological 3D printing technology, biomaterials, and regenerative medicine [2][43]. - The company offers a comprehensive range of services, including digital design, cell amplification, biological 3D printing, and quantitative detection [2][47]. - Regenovo has developed domestic alternatives for biodegradable biomedical materials and provides live tissue models for pharmaceutical and cosmetic evaluations [2][47]. Group 2: Business Model - The business model includes providing additive manufacturing equipment and materials, along with customized solutions for clients [3][47]. - The company also offers additive manufacturing services to produce complex components or products for various applications [3][47]. Group 3: Product Offerings - Regenovo's product line includes: - Bio-Architect® SR PRO: A high-performance desktop biological 3D printer designed for small to medium-sized research labs [4][11]. - Bio-Architect® WS: A workstation-level biological 3D printer suitable for interdisciplinary research [12][18]. - Bio-Architect® SR: A desktop biological 3D printer for exploratory research in regenerative medicine [18][24]. - Bio-Architect® PR PRO: A high-precision DLP biological 3D printer for tissue engineering and organ-on-chip applications [25][29]. - Bio-Architect® PR: A multi-material DLP printer for micro-needle and microfluidic chip applications [30][34]. Group 4: Technological Innovations - Regenovo has undertaken significant national research projects and holds 179 patents related to biological 3D printing and materials [35]. - The company integrates AI algorithms to enhance printing efficiency and model fidelity in organ-like structures [35]. - Innovations include deep learning for system calibration and monitoring, as well as machine learning for non-destructive testing of 3D printed organ models [35]. Group 5: Upcoming Events - The founder, Xu Ming'en, will present on "Intelligent Manufacturing and Detection Technology Equipment Research for Biomaterials" at the 2025 Polymer 3D Printing Materials Summit Forum [1][35].